Precigen, Inc. (PGEN)
NASDAQ: PGEN · Real-Time Price · USD
5.14
-1.80 (-25.94%)
At close: Nov 2, 2026, 4:00 PM EST
5.19
+0.05 (0.97%)
After-hours: Nov 2, 2026, 7:54 PM EST
Precigen Market Cap
Precigen has a market cap or net worth of $1.84 billion as of November 2, 2026. It is the 5,682nd most valuable company in the world and the 1,627th biggest in the United States. Its market cap has increased by 49.18% in one year.
Market Cap
1.84B
Enterprise Value
1.90B
1-Year Change
49.18%
Global Rank
Country Rank
#1,627 United States
Category
ChartMarket Cap Chart
Since August 8, 2013, Precigen's market cap has decreased from $2.32B to $1.84B, a decrease of -20.68%. That is a compound annual growth rate of -1.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 1.84B | 24.43% |
| Dec 31, 2025 | 1.48B | 350.91% |
| Dec 31, 2024 | 328.00M | -1.68% |
| Dec 29, 2023 | 333.60M | 5.44% |
| Dec 30, 2022 | 316.40M | -58.75% |
| Dec 31, 2021 | 767.00M | -59.45% |
| Dec 31, 2020 | 1.89B | 112.19% |
| Dec 31, 2019 | 891.50M | -0.66% |
| Dec 31, 2018 | 897.40M | -35.47% |
| Dec 29, 2017 | 1.39B | -51.74% |
| Dec 30, 2016 | 2.88B | -17.89% |
| Dec 31, 2015 | 3.51B | 26.82% |
| Dec 31, 2014 | 2.77B | 19.88% |
| Dec 31, 2013 | 2.31B | -0.51% |
| Aug 8, 2013 | 2.32B | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zai Lab | 2.74B |
| Beam Therapeutics | 2.72B |
| MBX Biosciences | 2.69B |
| Arcus Biosciences | 2.62B |
| ADMA Biologics | 2.56B |
| Recursion Pharmaceuticals | 2.41B |
| NewAmsterdam Pharma Company | 2.40B |
| Celldex Therapeutics | 2.36B |